Breakthrough Demonstration of Single Cell Technology’s Antibody Discovery Process

San Jose, CA June 2, 2016 Single Cell Technology, Inc., (SCT) today announced their revolutionary antibody discovery technology correctly extracts the two DNA sequences of high affinity antibodies over 95% of the time. These results were confirmed when SCT’s antibodies were molecularly reconstructed by Lake Pharma, a leading contract research organization, and compared to an…

Details

Chair of the University of Pittsburgh Department of Immunology joins Single Cell Technology’s Scientific Advisory Board

San Jose, CA April 28, 2016 Single Cell Technology, Inc. (SCT) today announced the appointment of Mark J. Shlomchik, M.D., Ph.D. to its Scientific Advisory Board.  Dr. Shlomchik currently surves as the Chair of the Department of Immunology, School of Medicine, University of Pittsburgh.  Dr. Shlomchik received his medical and doctoral degrees from the University…

Details